Phase I safety and acceptability study of the vaginal microbicide agent PMPA [tenofovir] gel.

Trial Profile

Phase I safety and acceptability study of the vaginal microbicide agent PMPA [tenofovir] gel.

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Feb 2012

At a glance

  • Drugs Tenofovir (Primary)
  • Indications HIV infections
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Feb 2012 Actual end date (Dec 2005) added as reported by ClinicalTrials.gov.
    • 16 Feb 2012 Planned number of patients changed from 96 to 120 as reported by ClinicalTrials.gov.
    • 01 Dec 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top